Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with type 2 diabetes
Journal
Clinical endocrinology
Journal Volume
79
Journal Issue
2
Date Issued
2013-08
Abstract
Elevated YKL-40 concentrations have been observed in both coronary heart disease (CHD) and diabetes. Thus, YKL-40 may play a role in pathogenesis of CHD in patients with diabetes. We evaluated whether plasma YKL-40 concentration can predict all-cause and cardiovascular mortality in individuals with type 2 diabetes.
SDGs
Other Subjects
glycoprotein gp 39; unclassified drug; YKL 40 protein; adult; aged; article; cardiovascular disease; cardiovascular mortality; cohort analysis; controlled study; enzyme linked immunosorbent assay; female; human; major clinical study; male; mortality; non insulin dependent diabetes mellitus; observational study; priority journal; prospective study; protein blood level; survival; Adipokines; Aged; Biological Markers; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 2; Female; Humans; Lectins; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Survival Analysis; Taiwan
Type
journal article